Columbia Partners Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-47,180
Closed -$704K 273
2016
Q4
$704K Sell
47,180
-192,988
-80% -$3.42M 0.06% 261
2016
Q3
$5.26M Sell
240,168
-95,308
-28% -$2.12M 0.41% 87
2016
Q2
$6.65M Buy
335,476
+202,864
+153% +$3.45M 0.49% 67
2016
Q1
$2.25M Sell
132,612
-314,160
-70% -$5.25M 0.16% 170
2015
Q4
$9.15M Sell
446,772
-172,776
-28% -$3.6M 0.63% 49
2015
Q3
$13.3M Sell
619,548
-110,344
-15% -$2.46M 0.93% 16
2015
Q2
$14.6M Sell
729,892
-197,132
-21% -$3.46M 0.9% 20
2015
Q1
$14.4M Buy
927,024
+272,008
+42% +$4.11M 0.77% 32
2014
Q4
$9.01M Buy
655,016
+378,904
+137% +$4.64M 0.47% 84
2014
Q3
$2.76M Buy
276,112
+49,788
+22% +$509K 0.14% 178
2014
Q2
$2.24M Buy
+226,324
New +$2.01M 0.1% 206

Other funds holding DXCM

Columbia Partners Investment Management's DXCM Position: Q1 2017 in Review

Columbia Partners Investment Management sold out of DexCom (DXCM) in Q1 2017, closing a stake of 47,180 shares — an estimated $704K sold.

Columbia Partners Investment Management first reported a position in DXCM in Q2 2014 and held it in 11 quarters. The position peaked at $14.6M in Q2 2015. 321 funds tracked by Wall St. Rank hold DXCM as of Q1 2017.

  • Columbia Partners Investment Management reported no remaining DexCom position as of Q1 2017 after selling out during the quarter.
  • Columbia Partners Investment Management sold 47,180 DexCom shares in Q1 2017, an estimated $704K.
  • Columbia Partners Investment Management first reported a position in DexCom in Q2 2014 and held it in 11 quarters.
  • Columbia Partners Investment Management's DexCom position peaked at $14.6M in Q2 2015.
  • 321 funds tracked by Wall St. Rank held DexCom as of Q1 2017.

Based on Columbia Partners Investment Management's 13F filing for Q1 2017, filed 5 Jun 2017.